Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paragh

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Journal of Muscle Research and Cell Motility|April 30, 2015
Effects of fluvastatin and coenzyme Q10 on skeletal muscle in normo- and hypercholesterolaemic ratsJ Vincze, Á Jenes, M Füzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 22, 2017
Adipokines as atherothrombotic risk factors in obese subjects: Associations with haemostatic markers and common carotid wall thicknessÉ Csongrádi, M Káplár, B Nagy, et al.
Current Medical Research and Opinion|July 24, 2001
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trialD R Illingworth, J R Crouse, D B Hunninghake, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Journal of Muscle Research and Cell Motility|April 30, 2015
Effects of fluvastatin and coenzyme Q10 on skeletal muscle in normo- and hypercholesterolaemic ratsJ Vincze, Á Jenes, M Füzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 22, 2017
Adipokines as atherothrombotic risk factors in obese subjects: Associations with haemostatic markers and common carotid wall thicknessÉ Csongrádi, M Káplár, B Nagy, et al.
Current Medical Research and Opinion|July 24, 2001
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trialD R Illingworth, J R Crouse, D B Hunninghake, et al.
Pageof 7